<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Evans</surname>
    <given-names>T. G.</given-names>
   </name>
   <name>
    <surname>Bernstein</surname>
    <given-names>D. I.</given-names>
   </name>
   <name>
    <surname>Raborn</surname>
    <given-names>G. W.</given-names>
   </name>
   <name>
    <surname>Harmenberg</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kowalski</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Spruance</surname>
    <given-names>S. L.</given-names>
   </name>
  </person-group> (
  <year>2000</year>). 
  <article-title>Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.</article-title>
  <source>
   <italic>Antimicrob. Agents Chemother.</italic>
  </source>
  <volume>46</volume>
  <fpage>1870</fpage>â€“
  <lpage>1874</lpage>. 
  <pub-id pub-id-type="doi">10.1128/aac.46.6.1870-1874.2002</pub-id>
  <?supplied-pmid 12019102?>
  <pub-id pub-id-type="pmid">12019102</pub-id>
 </mixed-citation>
</ref>
